A flexible peptide linker enhances the immunoreactivity of two copies HBsAg preS1 (21-47) fusion protein

Journal of Biotechnology

Volumn 107, Issue 1, 2004, Pages 83-90

  Hu, Weiguo ^a   Li, Feng ^a   Yang, Xingxiu ^a   Li, Zhen ^a   Xia, Hengchuan ^a   Li, Guangdi ^a   Wang, Yuan ^a   Zhang, Zuchuan ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Anti preS1 (21 47) antibody; E. coli expression; Flexible peptide linker; GST fusion protein; Hepatitis B virus (HBV) preS1 peptide

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANTIBODIES; BIOSYNTHESIS; DIAGNOSIS; ENZYMES; ESCHERICHIA COLI; IMMUNOLOGY; PATIENT TREATMENT; PURIFICATION; VIRUSES;

IMMUNOREACTIVITY;

BIOTECHNOLOGY;

GLUTATHIONE TRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HYBRID PROTEIN; MEMBRANE PROTEIN; VIRUS PROTEIN;

AFFINITY CHROMATOGRAPHY; ANTIBODY DETECTION; ARTICLE; BINDING SITE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE VECTOR; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; VIRUS NEUTRALIZATION;

HEPATITIS B VIRUS; VECTORS;

EID: 0346993605     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2003.09.009     Document Type: Article

References (22)

1. Blumberg B.S. Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7121-7125.
2. Budkowska A., Dubreuil P., Capel F., Pillot J. Hepatitis B virus preS gene encoded antigenic specificity and anti-preS1 antibody: relationship between anti-preS response and recovery. Hepatology. 6:1986;360-368.
3. Budkowska A., Dubreuil P., Poynard T., Marcellin P., Loriot M.A., Maillard P., Pillot J. Anti-preS responses and viral clearance in chronic hepatitis B virus infection. Hepatology. 1:1992;26-31.
4. Coursaget P., Buisson Y., Bourdil C., Yvonnet B., Moline C., Diop M.T., Chiron J.P., Bao O., Diop-Mar J. Antibody response to preS1 in hepatitis B virus induced liver disease and after immunization. Res. Virol. 141:1990;536-570.
5. Gerlich W.H., Heermann K.H., Lu X. Function of hepatitis B surface proteins. Arch. Virol. 4(Suppl.):1992;129-132.
6. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.S., Novotny J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R., Oppermann H. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv anologue produced in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5879-5883.
7. Kane M. Global program for control of hepatitis B infection. Vaccine. 131(Suppl.):1995;47-49.
8. Klinkert M.Q., Theilmann L., Pfaff E., Schaller H. Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection. J. Virol. 58:1986;522-525.
9. Lee C.L., Ko Y.C. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics. 99:1997;351-353.
10. Madalinski K., Sylvan S.P., Hellstrom U., Mikolajewicz J., Zembrzuska-Sadkowska E., Piontek E. Antibody responses to preS components after immunization of children with low doses of BioHepB. Vaccine. 20:2001;92-97.
11. Maeng C.Y., Ryu C.J., Gripon P., Guguen-Guillouzo C., Hong H.J. Fine mapping of virus-neutralizing epitopes on hepatitis B virus preS1. Virology. 270:2000;9-16.
12. Molik A.H., Lee W.M. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann. Intern. Med. 132:2000;723-731.
13. Neurath A.R., Seto B., Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine. 7:1989;234-236.
14. Persing D.H., Varmus H.E., Ganem D. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science. 234:1986;1388-1392.
15. Pontiss P., Ruvoletto M.G., Gerlich W.H., Heermann K.H., Bardini R., Alberti A. Identification for an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology. 173:1989;522-530.
16. Sidorkiewicz M., Plucienniczak G., Plucienniczak A. Expression and characterization of the multiplied, recombinant preS1 antigen of hepatitis B virus. Arch. Virol. 140:1995;1935-1944.
17. Smith D.B., Johnson K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathion S-transferase. Gene. 67:1988;31-40.
18. Theilmann L., Burkardt H.D., Galle P.R., Gemelin K., Kommerell B., Pfaff E. Detection of antibodies against preS1 proteins in sera from patients with hepatitis B virus infection by ELISA using a preS fusion protein expressed in E. coli. Alzheimer Forsh Drug Res. 38:1988;1856-1858.
19. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature. 317:1985;489-495.
20. Wei J., Liu X.J., Wang Y.Q., Lu Z.M., Li G.D., Wang Y., Zhang Z.C. Development of the diagnostic immunoassay to detect anti-PreS1 (21-47aa) antibody - a marker suggesting the health improvement of hepatitis B patients. Clin. Chim. Acta. 317:2002;159-169.
21. Wu X.F., Zhou Y.Z., Feng Z.M., Li Z.P., Xia S.Y. Cloning and restriction mapping of human HBV genome serotype adr. Sci. Sin. (Ser. B). 26:1983;954-960. (in Chinese).
22. Yang H.L., Cao H.T., Li M.Y., Ping P.F., Li G.D., Zhang Z.C. Development of the diagnostic kit to detect preS1 protein-marker of the intact hepatitis B virus Dane particle. Shanghai J. Med. Lab. Sci. 10:1995;204-206. (in Chinese).